Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GHEN Corporation is a prominent Japanese biotechnology company specializing in the production of Specific Pathogen Free (SPF) eggs and poultry genetics. As a critical supplier to the global pharmaceutical industry, the company provides the essential biological substrates required for the manufacturing of human and veterinary vaccines, including those for influenza. GHEN operates sophisticated, biosecure facilities to ensure the highest standards of purity and reliability for its biological products. In addition to vaccine support, the company offers comprehensive avian diagnostic services and advanced breeding technologies. Headquartered in Gifu, Japan, GHEN is a key subsidiary of the EW Group, supporting both public health and food security initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GHEN Corporation.